Genentech ยท 1 day ago
2026 Summer Intern - AIBT
Genentech is a leading biotechnology company focused on innovation in healthcare. They are seeking a motivated summer intern to evaluate foundation models for transcriptomic prediction, contributing to impactful projects in the field of computational sciences.
BiotechnologyLife ScienceManufacturing
Responsibilities
Work on evaluating the generalization performance of foundation models for transcriptomic prediction using large-scale perturb-seq data
Implement a systematic benchmarking framework to assess how models perform on two critical challenges: predicting gene expression responses for previously unseen gene perturbations and transferring predictions across cellular contexts
Qualification
Required
You must be pursuing a PhD (enrolled student)
Statistics, Computational Biology, Bioinformatics, Computer Science, or related fields
Proficient in coding with Python
Deep knowledge of statistical principles, linear algebra, and regression analysis
Previous experience working with genomic data, especially single-cell data, is highly desirable
Preferred
Good understanding of cancer biology, and signaling pathways
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid internship
A stipend will be provided to help alleviate costs associated with the internship
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Recent News
2026-01-07
Company data provided by crunchbase